Background: Limited published literature exists on the utility and standardization of anti-
phospholipase A2 receptor (anti-PLA2R) immunohistochemistry (IHC) for the diagnosis of …

Introduction: Patients with idiopathic membranous nephropathy (IMN) are particularly
susceptible to thromboembolism (TE). The phospholipase A2 receptor (PLA2R) antibody …

The phospholipase A 2 receptor (PLA 2 R) is the major target antigen in idiopathic
membranous nephropathy. The technique for measuring antibodies against PLA 2 R and …

Background: According to the renal phospholipase A2 receptor (PLA2R)
immunohistochemistry, idiopathic membranous nephropathy (iMN) could be categorized …

Introduction Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome
in native kidney biopsies from adults. In 2009, antibodies to the M-type receptor of …

Purpose The meta-analysis aims to investigate the relationship between anti-phospholipase
A2 receptor autoantibody (anti-PLA2R) and clinical characteristics and adverse outcomes of …

Objectives This study aimed to establish time-resolved fluorescence immunoassays to
quantitatively detect the autoantibodies targeting different epitopes of M-type phospholipase …

Kidney biopsy is the gold standard to diagnose membranous nephropathy (MN).
Approximately 70%-80% of patients with primary MN have anti-phospholipase A2 receptor …

Autoantibodies against M-type phospholipase A2 receptor (PLA2R) serve as specific
biomarkers for idiopathic membranous nephropathy (IMN), and its quantification helps …